COR
Price
$332.56
Change
-$29.20 (-8.07%)
Updated
Feb 4, 02:33 PM (EDT)
Capitalization
70.37B
Earnings call today
Intraday BUY SELL Signals
SNYR
Price
$1.79
Change
-$0.07 (-3.76%)
Updated
Feb 4, 03:02 PM (EDT)
Capitalization
21.38M
Intraday BUY SELL Signals
Interact to see
Advertisement

COR vs SNYR

Header iconCOR vs SNYR Comparison
Open Charts COR vs SNYRBanner chart's image
Cencora
Price$332.56
Change-$29.20 (-8.07%)
Volume$1.06K
Capitalization70.37B
Synergy CHC
Price$1.79
Change-$0.07 (-3.76%)
Volume$1K
Capitalization21.38M
COR vs SNYR Comparison Chart in %
COR
Daily Signal:
Gain/Loss:
SNYR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
COR vs. SNYR commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COR is a Hold and SNYR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (COR: $361.75 vs. SNYR: $1.86)
Brand notoriety: COR and SNYR are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: COR: 107% vs. SNYR: 135%
Market capitalization -- COR: $70.37B vs. SNYR: $21.38M
COR [@Medical Distributors] is valued at $70.37B. SNYR’s [@Medical Distributors] market capitalization is $21.38M. The market cap for tickers in the [@Medical Distributors] industry ranges from $105.05B to $0. The average market capitalization across the [@Medical Distributors] industry is $11.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COR’s FA Score shows that 4 FA rating(s) are green whileSNYR’s FA Score has 0 green FA rating(s).

  • COR’s FA Score: 4 green, 1 red.
  • SNYR’s FA Score: 0 green, 5 red.
According to our system of comparison, COR is a better buy in the long-term than SNYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COR’s TA Score shows that 6 TA indicator(s) are bullish while SNYR’s TA Score has 3 bullish TA indicator(s).

  • COR’s TA Score: 6 bullish, 4 bearish.
  • SNYR’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, COR is a better buy in the short-term than SNYR.

Price Growth

COR (@Medical Distributors) experienced а +1.58% price change this week, while SNYR (@Medical Distributors) price change was -8.82% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.61%. For the same industry, the average monthly price growth was +6.05%, and the average quarterly price growth was +10.32%.

Reported Earning Dates

COR is expected to report earnings on Feb 04, 2026.

Industries' Descriptions

@Medical Distributors (+1.61% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COR($70.4B) has a higher market cap than SNYR($21.4M). COR has higher P/E ratio than SNYR: COR (45.45) vs SNYR (6.79). COR YTD gains are higher at: 7.106 vs. SNYR (0.000). COR has higher annual earnings (EBITDA): 3.75B vs. SNYR (8.77M). COR has more cash in the bank: 4.36B vs. SNYR (1.01M). SNYR has less debt than COR: SNYR (25.1M) vs COR (7.66B). COR has higher revenues than SNYR: COR (321B) vs SNYR (34.6M).
CORSNYRCOR / SNYR
Capitalization70.4B21.4M328,972%
EBITDA3.75B8.77M42,735%
Gain YTD7.1060.000-
P/E Ratio45.456.79670%
Revenue321B34.6M927,746%
Total Cash4.36B1.01M433,002%
Total Debt7.66B25.1M30,522%
FUNDAMENTALS RATINGS
COR vs SNYR: Fundamental Ratings
COR
SNYR
OUTLOOK RATING
1..100
2210
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
285
SMR RATING
1..100
12100
PRICE GROWTH RATING
1..100
1587
P/E GROWTH RATING
1..100
2167
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNYR's Valuation (55) in the null industry is somewhat better than the same rating for COR (97) in the Real Estate Investment Trusts industry. This means that SNYR’s stock grew somewhat faster than COR’s over the last 12 months.

COR's Profit vs Risk Rating (2) in the Real Estate Investment Trusts industry is significantly better than the same rating for SNYR (85) in the null industry. This means that COR’s stock grew significantly faster than SNYR’s over the last 12 months.

COR's SMR Rating (12) in the Real Estate Investment Trusts industry is significantly better than the same rating for SNYR (100) in the null industry. This means that COR’s stock grew significantly faster than SNYR’s over the last 12 months.

COR's Price Growth Rating (15) in the Real Estate Investment Trusts industry is significantly better than the same rating for SNYR (87) in the null industry. This means that COR’s stock grew significantly faster than SNYR’s over the last 12 months.

COR's P/E Growth Rating (21) in the Real Estate Investment Trusts industry is somewhat better than the same rating for SNYR (67) in the null industry. This means that COR’s stock grew somewhat faster than SNYR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CORSNYR
RSI
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
60%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
33%
Advances
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 16 days ago
39%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
50%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
COR
Daily Signal:
Gain/Loss:
SNYR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TUA21.720.02
+0.09%
Simplify Short Term Trsy Futs Strat ETF
FDLS37.98N/A
N/A
Inspire Fidelis Multi Factor ETF
SIXF32.26-0.20
-0.60%
AllianzIM US Equity 6M Bfr10 Feb/Aug ETF
QQQP175.47-5.66
-3.13%
Tradr 2X Long Innovation100 QuarterlyETF
CIBR67.09-2.50
-3.59%
First Trust NASDAQ Cybersecurity ETF

COR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COR has been closely correlated with MCK. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if COR jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COR
1D Price
Change %
COR100%
-0.50%
MCK - COR
78%
Closely correlated
+0.54%
CAH - COR
56%
Loosely correlated
-0.42%
SHTDF - COR
17%
Poorly correlated
N/A
AHG - COR
10%
Poorly correlated
-0.68%
ACH - COR
9%
Poorly correlated
-0.44%
More

SNYR and

Correlation & Price change

A.I.dvisor tells us that SNYR and YI have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYR and YI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYR
1D Price
Change %
SNYR100%
+6.29%
YI - SNYR
6%
Poorly correlated
-4.86%
HSIC - SNYR
4%
Poorly correlated
-2.88%
COSM - SNYR
4%
Poorly correlated
+1.74%
CAH - SNYR
2%
Poorly correlated
-0.42%
COR - SNYR
-5%
Poorly correlated
-0.50%
More